HBM BIOVENTURES CAYMAN LTD 13D and 13G filings for ALX Oncology Holdings Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-12-27 4:05 pm Purchase |
2024-12-18 | 13G | ALX Oncology Holdings Inc. ALXO |
HBM BIOVENTURES CAYMAN LTD | 3,426,929 6.500% |
3,426,929 (New Position) |
Filing |